Botanix Pharmaceuticals Limited BXPHF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 2.29% | 10.81% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.29% | 10.81% | |||
| Cost of Revenue | 2.28% | 48.82% | |||
| Gross Profit | 2.29% | -10.67% | |||
| SG&A Expenses | 2.28% | 6.96% | |||
| Depreciation & Amortization | 2.29% | 0.74% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.29% | 11.79% | |||
| Operating Income | -2.29% | -12.27% | |||
| Income Before Tax | -2.28% | -16.51% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.28% | -16.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.28% | -16.51% | |||
| EBIT | -2.29% | -12.27% | |||
| EBITDA | -2.29% | -12.69% | |||
| EPS Basic | -1.85% | 1.82% | |||
| Normalized Basic EPS | 0.00% | 2.86% | |||
| EPS Diluted | -1.85% | 1.82% | |||
| Normalized Diluted EPS | 0.00% | 2.86% | |||
| Average Basic Shares Outstanding | 0.00% | 20.44% | |||
| Average Diluted Shares Outstanding | 0.00% | 20.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||